Learn more

SYMPHOGEN AS

Overview
  • Total Patents
    409
  • GoodIP Patent Rank
    15,828
  • Filing trend
    ⇩ 25.0%
About

SYMPHOGEN AS has a total of 409 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PHARMABCINE INC, ROCHE GLYCART AG and AMGEN RES MUNICH GMBH.

Patent filings per year

Chart showing SYMPHOGEN ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pedersen Mikkel Wandahl 114
#2 Koefoed Klaus 96
#3 Kragh Michael 87
#4 Lantto Johan 73
#5 Nielsen Lars Soegaard 66
#6 Bouquin Thomas 47
#7 Grandal Michael Monrad 45
#8 Jensen Allan 45
#9 Horak Ivan David 42
#10 Tolstrup Anne Bondgaard 42

Latest patents

Publication Filing date Title
WO2021058735A1 Cancer treatment with anti-met antibody compositions
US2021070876A1 Anti-cd73 antibodies and compositions
EP3695013A1 Compositions and methods for treating cancer with anti-egfr antibodies
US2019367616A1 Anti-PD-1 Antibodies and Compositions
CN108290953A Anti- PD-1 antibody and composition
JP2016182135A Anti-her2 antibodies and compositions
US2016089435A1 Pan-her antibody composition
AU2015316522A1 Anti-met antibodies and compositions
BR112014027291A2 humanized pan-her antibody compositions
AU2013200210A1 Recombinant anti-epidermal growth factor receptor antibody compositions
AU2013200209A1 Recombinant anti-epidermal growth factor receptor antibody compositions
BR112013010764A2 anti-her3 antibody composition, bispecific binding molecule, nucleic acid molecule, expression vector, polyclonal cell line, method for producing said composition, pharmaceutical composition and use of said composition
BR112013010718A2 pan-her antibody composition, pharmaceutical composition, method for producing and using said composition
TW201141519A Anti-HER2 antibodies and compositions
AU2010305150A1 Multiplex quantitation of individual recombinant proteins in a mixture by signature peptides and mass spectrometry
WO2011042024A1 Pharmacokinetic assessment of recombinant proteins in complex biological samples by pk-chromatography
CA2739476A1 Method for identifying and selecting drug candidates for combinatorial drug products
WO2010022737A1 Anti-cd5 antibodies
CN102137928A Method for cloning avian-derived antibodies
NZ603444A Recombinant anti-epidermal growth factor receptor antibody compositions